Artificial intelligence-driven approach for patient-focused drug development
- PMID: 37899963
- PMCID: PMC10601646
- DOI: 10.3389/frai.2023.1237124
Artificial intelligence-driven approach for patient-focused drug development
Abstract
Patients' increasing digital participation provides an opportunity to pursue patient-centric research and drug development by understanding their needs. Social media has proven to be one of the most useful data sources when it comes to understanding a company's potential audience to drive more targeted impact. Navigating through an ocean of information is a tedious task where techniques such as artificial intelligence and text analytics have proven effective in identifying relevant posts for healthcare business questions. Here, we present an enterprise-ready, scalable solution demonstrating the feasibility and utility of social media-based patient experience data for use in research and development through capturing and assessing patient experiences and expectations on disease, treatment options, and unmet needs while creating a playbook for roll-out to other indications and therapeutic areas.
Keywords: artificial intelligence; natural language processing; patient experience; patient-focused drug development; social media; text analytics; unmet needs.
Copyright © 2023 Karmalkar, Gurulingappa, Spies and Flynn.
Conflict of interest statement
PK and HG are current employees of Merck Data & AI Organization, Merck Group. ES and JF are current employees of EMD Serono Research & Development Institute, Inc.
Figures




Similar articles
-
Educational and Emotional Needs of Patients with Myelodysplastic Syndromes: An AI Analysis of Multi-Country Social Media.Adv Ther. 2023 Jan;40(1):159-173. doi: 10.1007/s12325-022-02277-0. Epub 2022 Sep 22. Adv Ther. 2023. PMID: 36136244 Free PMC article.
-
Using Social Media to Uncover Treatment Experiences and Decisions in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis.J Med Internet Res. 2019 Nov 22;21(11):e14285. doi: 10.2196/14285. J Med Internet Res. 2019. PMID: 31755871 Free PMC article.
-
Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review.JMIR Cancer. 2022 Sep 22;8(3):e39068. doi: 10.2196/39068. JMIR Cancer. 2022. PMID: 36136395 Free PMC article. Review.
-
Augmented Analytics Driven by AI: A Digital Transformation beyond Business Intelligence.Sensors (Basel). 2022 Oct 21;22(20):8071. doi: 10.3390/s22208071. Sensors (Basel). 2022. PMID: 36298421 Free PMC article.
-
Social media mining in drug development-Fundamentals and use cases.Drug Discov Today. 2021 Dec;26(12):2871-2880. doi: 10.1016/j.drudis.2021.08.012. Epub 2021 Sep 1. Drug Discov Today. 2021. PMID: 34481080 Review.
Cited by
-
Artificial intelligence-enabled social media listening to inform early patient-focused drug development: perspectives on approaches and strategies.Front Digit Health. 2024 Nov 20;6:1459201. doi: 10.3389/fdgth.2024.1459201. eCollection 2024. Front Digit Health. 2024. PMID: 39633966 Free PMC article.
-
Harnessing Artificial Intelligence to Overcome Key Challenges in Psychedelic Research and Therapy.ACS Med Chem Lett. 2024 Dec 11;16(1):3-7. doi: 10.1021/acsmedchemlett.4c00548. eCollection 2025 Jan 9. ACS Med Chem Lett. 2024. PMID: 39811120
-
One size fits all: Enhanced zero-shot text classification for patient listening on social media.Front Artif Intell. 2025 Feb 11;7:1397470. doi: 10.3389/frai.2024.1397470. eCollection 2024. Front Artif Intell. 2025. PMID: 40007771 Free PMC article.
-
From the Formation of Conceptual Framework to Regulatory Decision-Making: Considerations for the Developments of Patient-Reported Outcome Instruments.Drug Des Devel Ther. 2024 Dec 6;18:5759-5771. doi: 10.2147/DDDT.S490289. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39659950 Free PMC article. Review.
References
-
- Barbieri F., Camacho-Collados J., Anke L. E., Neves L. (2020). “TweetEval: unified benchmark and comparative evaluation for tweet classification,” in Findings of the Association for Computational (Linguistics: EMNLP Association for Computational Linguistics; ). 10.18653/v1/2020.findings-emnlp.148 - DOI
-
- Burkhardt S., Siekiera J., Glodde J., Andrade-Navarro M. A., Kramer S. (2020). Towards identifying drug side effects from social media using active learning and crowd sourcing. Pac. Symp. Biocomput. 25, 319–330. - PubMed
-
- Happell B., Cowin L., Roper C., Lakeman R., Cox L. (2020). “Nursing care in psychosocial health,” in Introducing Psychosocial health Nursing (London: Routledge; ). 10.4324/9781003116202-2 - DOI
LinkOut - more resources
Full Text Sources